Skip to main content
An official website of the United States government

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients with Head and Neck Cancer

Trial Status: complete

This randomized pilot early phase I trial studies how well metformin hydrochloride works in affecting cytokines and exosomes in patients with head and neck cancer. Metformin hydrochloride may reduce the metabolic activity of cancer cells and of surrounding supportive tissues.